北美快速检测试剂盒市场预测至 2030 年 - 区域分析 - 按类型（快速抗原检测、快速抗体检测等）、产品（非处方快速检测试剂盒和专业快速检测试剂盒）、技术（横向流动测定、固相、凝集、免疫斑点测定和基于细胞成分）、应用（血糖检测、传染病检测、怀孕和生育、心脏代谢检测等）和最终用户（医院和诊所、家庭护理、诊断中心等）
遗传和传染病患病率上升推动北美快速检测试剂盒市场发展
MJH Life Sciences (US) 2022 年的一份报告估计，全球每年有 30 万新生儿患有镰状细胞病。据 CDC 称，每 500 名非裔美国人中就有 1 人患有镰状细胞病。世界卫生组织 (WHO) 最新的《2022 年世界疟疾报告》 (WMR) 指出，2021 年全球报告了近 2.47 亿例新发疟疾病例，而 2020 年记录的病例为 2.45 亿例。根据同一消息来源，2021 年因疟疾造成的死亡人数为 619,000 人。
镰状细胞扫描是一种快速检测镰状细胞性贫血的方法，具有高灵敏度和特异性。快速诊断测试 (RDT) 通过检测人体血液中疟原虫的存在来帮助诊断疟疾。在无法获得高质量显微镜服务的地方，放射学诊断技术被用作临床或基于显微镜的诊断的替代方案。COVID-19 大流行对快速检测试剂盒市场产生了重大影响。几乎所有诊断测试都使用实时 PCR 来检测出现 SARS-CoV-2 感染症状的人。快速检测试剂盒几乎无处不在，坚固耐用且可靠。大多数分子生物学实验室都使用快速检测技术，包括扩增特定 DNA 片段以进行基因分型、克隆和单核苷酸变异分析。因此，遗传和传染病发病率的上升推动了快速检测试剂盒市场的增长。
北美快速检测试剂盒市场概览
在研究和治疗中，CRISPR 和 PCR 等基因合成和编辑工具的快速应用需要有助于快速量化、改变和观察的检测方法。美国正在寻求公共和私人组织的大量资金，预计将在先进的研究方法上进行大量投资，并有望在快速检测试剂盒市场中占据领先地位。在 SARS-CoV-2 Delta 和 Omicron 占主导地位的大流行期间，家庭测试的使用量迅速增加。据 CDC 称，2023 年 4 月，全美共运送了 7000 多万个检测试剂盒。
北美快速检测试剂盒市场收入及 2030 年预测（百万美元）
北美快速检测试剂盒市场细分
北美快速检测试剂盒市场根据类型、产品、技术、应用、最终用户和国家/地区进行细分。根据类型，北美快速检测试剂盒市场细分为快速抗原检测、快速抗体检测等。快速抗原检测细分市场在 2022 年占据了最大的市场份额。
就产品而言，北美快速检测试剂盒市场分为非处方快速检测试剂盒和专业快速检测试剂盒。非处方快速检测试剂盒部分在 2022 年占据了更大的市场份额。
按技术划分，北美快速检测试剂盒市场细分为横向流动测定、固相、凝集、免疫斑点测定和基于细胞成分。横向流动测定部分在 2022 年占据了最大的市场份额。
根据应用，北美快速检测试剂盒市场分为血糖检测、传染病检测、妊娠和生育、心脏代谢检测等。血糖检测部分在 2022 年占据了最大的市场份额。
就最终用户而言，北美快速检测试剂盒市场细分为医院和诊所、家庭护理、诊断中心等。医院和诊所部分在 2022 年占据了最大的市场份额。
根据国家/地区，北美快速检测试剂盒市场细分为美国、加拿大和墨西哥。 2022 年，美国占据了北美快速检测试剂盒市场的主导地位。
F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、广州万孚生物科技有限公司、Denka Co Ltd、Abbott Laboratories、Trinity Biotech Plc、SD Biosensor Inc、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA 和 Beckman Coulter Inc 是北美快速检测试剂盒市场的一些领先企业。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - North America Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. North America Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Rapid Test Kits Market - Country Analysis
11.1 North America: Rapid Test Kits Market
11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 United States
11.1.1.1.1 Overview
11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 Canada
11.1.1.3.1 Overview
11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Mexico
11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 OraSure Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Guangzhou Wondfo Biotech Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Denka Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Abbott Laboratories
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Trinity Biotech Plc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 SD Biosensor Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Beckman Coulter Inc
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. OraSure Technologies Inc
10. Guangzhou Wondfo Biotech Co Ltd
11. Denka Co Ltd
12. Abbott Laboratories
13. Trinity Biotech Plc
14. SD Biosensor Inc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. DiaSorin SpA
18. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.